Keywords: gilead, sciences, sees, success, flu, drug, roche

Gilead Sciences Sees Success With Flu Drug

Article | 02 October 1997

Gilead and Roche have reported data from two Phase II studies whichdemonstrate that their orally-active neuraminidase inhibitor, GS 4104 (Ro 64-0796), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Relenza

Zanamivir

Nystatin

Go to drug listing